315 related articles for article (PubMed ID: 24390320)
21. Multifaceted HIV-1 Vif interactions with human E3 ubiquitin ligase and APOBEC3s.
Hu Y; Knecht KM; Shen Q; Xiong Y
FEBS J; 2021 Jun; 288(11):3407-3417. PubMed ID: 32893454
[TBL] [Abstract][Full Text] [Related]
22. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.
Jäger S; Kim DY; Hultquist JF; Shindo K; LaRue RS; Kwon E; Li M; Anderson BD; Yen L; Stanley D; Mahon C; Kane J; Franks-Skiba K; Cimermancic P; Burlingame A; Sali A; Craik CS; Harris RS; Gross JD; Krogan NJ
Nature; 2011 Dec; 481(7381):371-5. PubMed ID: 22190037
[TBL] [Abstract][Full Text] [Related]
23. Dissection of the HIV Vif interaction with human E3 ubiquitin ligase.
Wolfe LS; Stanley BJ; Liu C; Eliason WK; Xiong Y
J Virol; 2010 Jul; 84(14):7135-9. PubMed ID: 20463065
[TBL] [Abstract][Full Text] [Related]
24. Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.
Zuo T; Liu D; Lv W; Wang X; Wang J; Lv M; Huang W; Wu J; Zhang H; Jin H; Zhang L; Kong W; Yu X
J Virol; 2012 May; 86(10):5497-507. PubMed ID: 22379088
[TBL] [Abstract][Full Text] [Related]
25. Design of Vif-Derived Peptide Inhibitors with Anti-HIV-1 Activity by Interrupting Vif-CBFβ Interaction.
Gai Y; Duan S; Wang S; Liu K; Yu X; Yang C; Li G; Zhou Y; Yu B; Wu J; Wang C; Yu X
Viruses; 2024 Mar; 16(4):. PubMed ID: 38675833
[TBL] [Abstract][Full Text] [Related]
26. Vif-CBFβ interaction is essential for Vif-induced cell cycle arrest.
Du J; Rui Y; Zheng W; Li P; Kang J; Zhao K; Sun T; Yu XF
Biochem Biophys Res Commun; 2019 Apr; 511(4):910-915. PubMed ID: 30851937
[TBL] [Abstract][Full Text] [Related]
27. Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif.
Guo Y; Dong L; Qiu X; Wang Y; Zhang B; Liu H; Yu Y; Zang Y; Yang M; Huang Z
Nature; 2014 Jan; 505(7482):229-33. PubMed ID: 24402281
[TBL] [Abstract][Full Text] [Related]
28. CBFβ enhances de novo protein biosynthesis of its binding partners HIV-1 Vif and RUNX1 and potentiates the Vif-induced degradation of APOBEC3G.
Miyagi E; Kao S; Yedavalli V; Strebel K
J Virol; 2014 May; 88(9):4839-52. PubMed ID: 24522927
[TBL] [Abstract][Full Text] [Related]
29. The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation.
Donahue JP; Vetter ML; Mukhtar NA; D'Aquila RT
Virology; 2008 Jul; 377(1):49-53. PubMed ID: 18499212
[TBL] [Abstract][Full Text] [Related]
30. Identification of HIV-1 Vif regions required for CBF-β interaction and APOBEC3 suppression.
Wang H; Liu B; Liu X; Li Z; Yu XF; Zhang W
PLoS One; 2014; 9(5):e95738. PubMed ID: 24810617
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
[TBL] [Abstract][Full Text] [Related]
32. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
33. Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif.
Xiao Z; Ehrlich E; Yu Y; Luo K; Wang T; Tian C; Yu XF
Virology; 2006 Jun; 349(2):290-9. PubMed ID: 16530799
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a novel Cullin5 binding domain in HIV-1 Vif.
Xiao Z; Xiong Y; Zhang W; Tan L; Ehrlich E; Guo D; Yu XF
J Mol Biol; 2007 Oct; 373(3):541-50. PubMed ID: 17869271
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 Vif N-terminal motif is required for recruitment of Cul5 to suppress APOBEC3.
Evans SL; Schön A; Gao Q; Han X; Zhou X; Freire E; Yu XF
Retrovirology; 2014 Jan; 11():4. PubMed ID: 24422669
[TBL] [Abstract][Full Text] [Related]
36. Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins.
Wang J; Zhang W; Lv M; Zuo T; Kong W; Yu X
J Virol; 2011 Dec; 85(23):12482-91. PubMed ID: 21957297
[TBL] [Abstract][Full Text] [Related]
37. Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.
Dang Y; Davis RW; York IA; Zheng YH
J Virol; 2010 Jun; 84(11):5741-50. PubMed ID: 20335268
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.
Mehle A; Goncalves J; Santa-Marta M; McPike M; Gabuzda D
Genes Dev; 2004 Dec; 18(23):2861-6. PubMed ID: 15574592
[TBL] [Abstract][Full Text] [Related]
39. Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G.
Luo K; Xiao Z; Ehrlich E; Yu Y; Liu B; Zheng S; Yu XF
Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11444-9. PubMed ID: 16076960
[TBL] [Abstract][Full Text] [Related]
40. ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.
Hüttenhain R; Xu J; Burton LA; Gordon DE; Hultquist JF; Johnson JR; Satkamp L; Hiatt J; Rhee DY; Baek K; Crosby DC; Frankel AD; Marson A; Harper JW; Alpi AF; Schulman BA; Gross JD; Krogan NJ
Cell Host Microbe; 2019 Jul; 26(1):86-99.e7. PubMed ID: 31253590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]